|
5
|
62
|
1k4uS |
Solution structure of the c-terminal sh3 domain of p67phox complexed with the c-terminal tail region of p47phox |
|
9
|
59
|
1gfdA |
Solution structure and ligand-binding site of the c-terminal sh3 domain of grb2 |
|
8
|
57
|
1kikA |
Sh3 domain of lymphocyte specific kinase (lck) |
|
11
|
67
|
1gl5A |
Nmr structure of the sh3 domain from the tec protein tyrosine kinase |
|
7
|
63
|
1h92A |
Sh3 domain of human lck tyrosine kinase |
|
12
|
58
|
2o88A |
Crystal structure of the n114a mutant of abl-sh3 domain complexed with a designed high-affinity peptide ligand: implications for sh3-ligand interactions |
|
11
|
67
|
6ipyA |
His-tagged fyn sh3 domain r96i mutant |
|
12
|
63
|
6ipzZ |
Fyn sh3 domain r96w mutant, crystallized with 18-crown-6 |
|
13
|
74
|
6c4sA |
Human csrc sh3 domain in complex with choline kinase fragment 60-69 |
|
58
|
202
|
6ghmC |
Structure of pp1 alpha phosphatase bound to aspp2 |
|
15
|
63
|
6nmwA |
Crystal structure of the human lyn sh3 domain |
|
16
|
77
|
6edfA |
Fragment of a tyrosine-protein kinase |
|
134
|
449
|
5mo4A |
Abl1 kinase (t334i_d382n) in complex with asciminib and nilotinib |
|
10
|
58
|
5l23A |
Crystal structure of the complex between the n-terminal sh3 domain of crkii and a proline-rich ligand |
|
107
|
339
|
5jmqA |
Crystal structures of a methyl transferase |
|
10
|
68
|
5ixfA |
Solution structure of the stam2 sh3 with amsh derived peptide complex |
|
12
|
56
|
5ihkA |
Crystal structure of the alpha spectrin sh3 domain mutant n47a |
|
10
|
58
|
5ih2A |
Structure, thermodynamics, and the role of conformational dynamics in the interactions between the n-terminal sh3 domain of crkii and proline-rich motifs in cabl |
|
128
|
447
|
5h0gA |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor (s)-2-(((1r,4s)-4-(4-amino-5-(4-phenoxyphenyl)-7h-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexyl)amino)-n,4-dimethylpentanamide |
|
6
|
56
|
5i11A |
Crystal structure of the intertwined form of the src tyrosine kinase sh3 domain t114s-q128r mutant |
|
125
|
447
|
5h0eA |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor (s)-2-(((1r,4s)-4-(4-amino-5-(4-phenoxyphenyl)-7h-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexyl)amino)-4-methylpentanamide |
|
124
|
449
|
6f3fA |
Autoinhibited src kinase bound to adp |
|
22
|
115
|
6b25A |
Crystal structure of human stac1 tandem sh3 domains (288-402) |
|
48
|
255
|
6amwA |
Abl1b regulatory module 'activating' conformation |
|
58
|
255
|
6amvA |
Abl 1b regulatory module 'inhibiting state' |
|
9
|
58
|
6atvA |
The molecular mechanisms by which ns1 of the 1918 spanish influenza a virus hijack host protein-protein interactions |
|
74
|
293
|
5yprA |
Crystal structure of psd-95 sh3-gk domain in complex with a synthesized inhibitor |
|
12
|
64
|
5xggA |
Crystal structure c-terminal sh3 domain of myosin ib from entamoeba histolytica |
|
12
|
57
|
4f16A |
Crystal structure of the alpha spectrin sh3 domain at ph 5 |
|
11
|
55
|
4f17A |
Crystal structure of the alpha spectrin sh3 domain at ph 9 |
|
15
|
65
|
4esrA |
Molecular and structural characterization of the sh3 domain of ahi-1 in regulation of cellular resistance of bcr-abl+ chronic myeloid leukemia cells to tyrosine kinase inhibitors |
|
13
|
58
|
4eikA |
Crystal structure of the human fyn sh3 domain in complex with the synthetic peptide vsl12 |
|
12
|
57
|
4d8dA |
Crystal structure of hiv-1 nef fyn-sh3 r96w variant |
|
32
|
163
|
4d8kA |
Crystal structure of a sh3-sh2 domains of a lymphocyte-specific protein tyrosine kinase (lck) from homo sapiens at 2.36 a resolution |
|
11
|
61
|
4cc3A |
Complex of human tuba c-terminal sh3 domain and mena proline-rich peptide - h3 |
|
10
|
67
|
4cc4B |
Complex of inlc of listeria monocytogenes and human tuba c-terminal sh3 domain |
|
12
|
63
|
4cc2A |
Complex of human tuba c-terminal sh3 domain with human n-wasp proline- rich peptide - p212121 |
|
12
|
58
|
4cc7A |
Crystal structure of the sixth or c-terminal sh3 domain of human tuba in complex with proline-rich peptides of n-wasp. space group p41 |
|
127
|
290
|
4bneA |
Pacsin2 interacts with membranes and actin-filaments |
|
59
|
202
|
4a63B |
Crystal structure of the p73-aspp2 complex at 2.6a resolution |
|
117
|
447
|
3vs6A |
Crystal structure of hck complexed with a pyrazolo-pyrimidine inhibitor tert-butyl {4-[4-amino-1-(propan-2-yl)-1h-pyrazolo[3,4-d]pyrimidin-3-yl]-2-methoxyphenyl}carbamate |
|
116
|
447
|
3vs2A |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 7-[cis-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7h-pyrrolo[2,3-d]pyrimidin-4-amine |
|
110
|
447
|
3vs4A |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 5-(4-phenoxyphenyl)-7-(tetrahydro-2h-pyran-4-yl)-7h-pyrrolo[2,3-d]pyrimidin-4-amine |
|
123
|
447
|
3vs3A |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 7-[trans-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7h-pyrrolo[2,3-d]pyrimidin-4-amine |
|
106
|
447
|
3vs7A |
Crystal structure of hck complexed with a pyrazolo-pyrimidine inhibitor 1-cyclopentyl-3-(1h-pyrrolo[2,3-b]pyridin-5-yl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine |
|
109
|
447
|
3vs0A |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor n-[4-(4-amino-7-cyclopentyl-7h-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]benzamide |
|
112
|
447
|
3vs1A |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 1-[4-(4-amino-7-cyclopentyl-7h-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]-3-phenylurea |
|
117
|
447
|
3vrzA |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 1-[4-(4-amino-7-cyclopentyl-7h-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]-3-benzylurea |
|
116
|
447
|
3vs5A |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 7-(1-methylpiperidin-4-yl)-5-(4-phenoxyphenyl)-7h-pyrrolo[2,3-d]pyrimidin-4-amine |
|
122
|
447
|
3vryA |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 4-amino-5-(4-phenoxyphenyl)-7h-pyrrolo[2,3-d]pyrimidin-7-yl-cyclopentane |
